NEW YORK (GenomeWeb News) – GeneGo today said it has integrated its MetaCore and MetaDrug products with GenomeQuest's Sequence Data Management platform.
As a result, scientists with particular genes of interest will be able to pass their gene lists with their associated expression values to GeneGo's pathway analysis software tools.
Being able to analyze large numbers of datasets, as millions of reads are reduced to manageable lists of genes of interest, and being able to visualize the location of those genes in specific pathways are a "significant accomplishment" in integrating 'omics software offerings, Don Gregory, GenomeQuest's director of field application scientists, said in a statement.
"Scientists will be able to quickly focus on their scientific questions, rather than manipulating large reads datasets and lists of thousands of genes," he said.
Julie Bryant, vice president of business development at GeneGo, which announced a next-gen sequencing integration deal with Omicsoft a week ago, added that the integration of the two firms' platforms will allow joint customers to seamlessly work with next-generation sequencing data in the context of pathways. "The integrated workflows will lead our users from raw sequence runs to functional hypothesis generation of drug targets and biomarkers," she said.